Back
Edesa Biotech, Inc. 10K Form
Sell
47
EDSA
Edesa Biotech, Inc.
Last Price:
$4.28
Seasonality Move:
-21.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EDSA News And Ratings
See the #1 stock for the next 7 days that we like better than EDSA
EDSA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.56 |
| Price / Book: | 7.64 |
Profitability
| EPS (TTM): | -1.14650 |
|---|---|
| Net Income (TTM): | $-7.8M |
| Gross Margin: | $-119.3K |
| Return on Equity: | -66.98% |
| Return on Assets: | -61.26% |
Edesa Biotech, Inc. Earnings Forecast
Key Edesa Biotech, Inc. Financial Ratios
-
Per Share Earnings over the last 18 years have been positive in 8 years.
Edesa Biotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EDSA |
| CUSIP: | 27966L |
| Website: | edesabiotech.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 16.82 |
| Quick Ratio: | 16.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
EDSA Technical Analysis vs Fundamental Analysis
Sell
47
Edesa Biotech, Inc. (EDSA)
is a Sell
Is Edesa Biotech, Inc. a Buy or a Sell?
-
Edesa Biotech, Inc. stock is rated a SellThe current Edesa Biotech, Inc. [EDSA] share price is $4.27. The Score for EDSA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.